Blaney McMurtry LLP
Blaney McMurtry LLP is a full-service law firm with expertise in the pharmaceutical, biologic, medical device, natural health products and cosmetic industries.
Our areas of expertise include:
INTELLECTUAL PROPERTY (IP)
• IP litigation, including pharmaceutical patent litigation and trademarks disputes;
• Patent, trademark and copyright protection and enforcement;
• Building and monetizing IP portfolios;
• Licensing, research and joint development agreements;
• Domain name protection and enforcement issues;
REGULATORY AND COMPLIANCE
• Health Canada submissions and review processes;
• Product recalls and detentions;
• Product liability and class actions;
• Pharmaceutical pricing and provincial formulary listing, including Patented Medicine Prices Review Board (PMPRB);
• Contesting decisions by regulatory authorities;
• Packaging, labelling, advertising and marketing issues;
• Clinical trial and quality agreements;
PRIVACY AND ACCESS TO INFORMATION
• Compliance with privacy legislation, including, requests under the Access to Information Act;
• Disclosure of clinical trial information;
• Privacy policies;
• Non-disclosure agreements;
CORPORATE AND COMMERCIAL SERVICES
• Incorporation, corporate governance, transactions, strategic tax planning, and financing;
• Contract manufacturing, research and co-development agreements;
• Joint ventures, partnership, mergers and corporate reorganizations;
• Corporate agreements, such as supply, distribution and product acquisition agreements; and
• Employment issues.
Related
Intertek Assuris
Intertek Assuris is an unparalleled team of industry-leading experts providing science-based assurance in quality, safety, and sustainability. Our global network of...
March 5, 2026
Lebelpharma inc.
With strong experience in pharmaceutical consultation, Ms. Nathalie Lebel founded the company Consultations Nathalie Lebel Inc. in 2008. With years, Nathalie and her team of...
February 26, 2025
PASB MedTech Solutions
PASB MedTech Solutions provides comprehensive consulting assistance to medical device firms, with a focus on complex regulatory and quality management requirements in major...
January 2, 2026

